Applications of 4-Amino-6-Hydroxy-2-Methylpyrimidine in Industrial Manufacturing

As a direct manufacturer, we supply 4-Amino-6-Hydroxy-2-Methylpyrimidine to customers operating advanced chemical synthesis lines across multiple industrial sectors. Below, we detail primary downstream applications and processing considerations based on real-world use in specialized industries.

1. Pharmaceutical Intermediate for Antiviral Drug Synthesis

4-Amino-6-Hydroxy-2-Methylpyrimidine serves as a core intermediate in the synthesis of specific nucleoside analogs, frequently utilized in the development of antiviral medications. Its role in the pyrimidine ring modification state makes it an essential building block for APIs such as certain reverse transcriptase inhibitors. Downstream manufacturers employ standard GMP-compliant synthesis and purification processes, adjusting ratios according to the required specification of the target intermediate within the broader API production route.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredients
• United States Pharmacopeia (USP) for related intermediates
• EU Guidelines for Good Manufacturing Practice for Medicinal Products
• FDA 21 CFR Part 211 (Finished Pharmaceutical)

Typical usage ratio

• 5%–20% as molar ratio relative to primary aldehyde or sugar used in condensation steps, subject to titration for yield optimization in pilot batches

Downstream process integration

• Introduced after the protection of precursor sugars, directly into nucleobase coupling under controlled temperature in anhydrous solvent systems
• Purified by crystallization or chromatography after main cyclization; further processed with halogenation or glycosylation steps depending on final API specification

Final product types

• Antiviral nucleoside analogs (e.g., lamivudine intermediates)
• Intermediates for hepatitis B and HIV drug APIs
• Bulk APIs subjected to regulatory registration
• Finished oral antiviral tablets

2. Intermediate for Veterinary Medicines

Animal pharmaceutical producers use this compound to build pyrimidine bases within veterinary drugs targeting viral, bacterial, and protozoal infections. Its chemical structure allows integration into precursor routes for modified cytosine and uracil derivatives, impacting susceptibility and absorption profiles in animal formulations. Validation of the process ensures compliance with veterinary GMPs and residue limit requirements for animal-derived food production.

Industry compliance standards

• VICH GL24 (Good Manufacturing Practice for Active Pharmaceutical Ingredients in Veterinary Drugs)
• Chinese Veterinary Pharmacopoeia (latest edition)
• European Pharmacopoeia for excipient and intermediate purity
• ISO 9001 for quality management in veterinary drug production

Typical usage ratio

• 10–25% relative to base precursor, dependent on API yield and stepwise reaction needs in multi-stage synthesis

Downstream process integration

• Dosed into reaction stages following initial ring closure of base heterocycle chain, utilizing staged solvent addition and pH control to favor high conversion rates
• Subjected to filtration and drying followed by direct incorporation into final API crystallization protocols

Final product types

• Veterinary cytostatic drugs
• Antiviral tablets and injectable solutions for livestock
• Premix powders for feed administration
• Finished veterinary pharmaceutical APIs

3. Synthesis of Plant Growth Regulators

Manufacturers in the crop protection sector use 4-Amino-6-Hydroxy-2-Methylpyrimidine as a precursor for synthesizing plant growth-regulating agents. The compound enables precise modification of pyrimidine-based skeletons that result in target molecules with specific auxin or cytokinin activities. The raw material plays a crucial part in intermediate coupling and stabilization prior to formulation into end-use agricultural products, with attention to agrochemical safety and environmental regulations.

Industry compliance standards

• FAO/WHO specifications for pesticide and plant growth regulator quality
• REACH Regulation (EC) No 1907/2006 for chemical safety
• China GB/T standards for agrochemical intermediates
• OECD guidelines for testing of chemicals in agricultural products

Typical usage ratio

• 12–18% relative to other coupling reactants; adjusted based on final regulator concentration requirement and field performance trials

Downstream process integration

• Charged into reactor following neutralization of initial base, often with controlled addition to minimize byproducts
• Purity confirmed by HPLC prior to downstream esterification and formulation into liquid concentrates or wettable powders

Final product types

• Plant growth regulator technical concentrates
• Pre-mix compounds for field dilution
• Tablet-type plant growth promoters
• Emulsion formulations for foliar spray

4. Pyrimidine Ring Building Block for Dyes and Pigments

The compound supports synthesis of specialty dyes and pigment intermediates that require functionalized pyrimidine moieties. Dye manufacturers incorporate the raw material at controlled points in the scaffold assembly for lightfastness enhancement, solubility modification, or electronic structure adjustment of the final chromophore. Process suitability relies on consistent purity and analytical traceability, and output products adhere to strict sectoral regulations for textile, digital ink, and plastic coloration.

Industry compliance standards

• OEKO-TEX® Standard 100 for finished textile dyes
• EN 71-3 for pigments in toys
• ECHA REACH pre-registration for dye precursors
• ISO 9001/14001 for pigment production traceability and safety

Typical usage ratio

• 8–14% based on the total molar sum in condensation reactions; adjusted for color intensity targets and batch consistency in final pigment

Downstream process integration

• Reacted with halogenated or aminated aromatic rings under temperature- and pH-controlled batch processes, followed by immediate quenching and purification steps
• Serves as end-stage precursor prior to oxidation or reduction in dye molecule elaboration

Final product types

• High-performance textile dyes
• Digital inkjet colorants
• Polymer-compatible pigments for plastics
• UV-resistant color additives for fiber spinning

5. Precursor for Specialty Photographic Chemicals

Producers of photographic processing agents and light-sensitive materials use this compound as a pyrimidine nucleus donor in the formulation of developer auxiliaries and spectral sensitizers. Its structure enhances selective reactivity in the preparation of molecules that adjust light absorption or transfer rates in silver halide-based photographic manufacturing. Batch records must demonstrate conformance to photochemical grade standards and trace heavy metals and impurity profiles.

Industry compliance standards

• ISO 18912 for photographic processing chemicals
• ANSI IT9.2 for imaging material stability
• RoHS limit for heavy metals in chemical components
• Internal laboratory analytical method specifications for batch QC

Typical usage ratio

• 2–6% in compound mixtures for developer auxiliaries; optimized to end-product light sensitivity and shelf-life requirements

Downstream process integration

• Added after initial emulsification stage, participating in controlled coupling reactions for auxiliary dye or sensitizer production
• Monitored using UV-vis spectrophotometry to verify intermediate conversion

Final product types

• Spectral sensitizer intermediates
• Photographic developers and fixing agents
• Photochemistry-grade additive blends
• Custom imaging chemical kits for film and photo paper